Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-39.34%
0%
-39.34%
6 Months
124.11%
0%
124.11%
1 Year
-28.44%
0%
-28.44%
2 Years
-2.18%
0%
-2.18%
3 Years
-72.61%
0%
-72.61%
4 Years
-87.28%
0%
-87.28%
5 Years
-91.2%
0%
-91.2%
Pure Biologics SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-175.48%
EBIT to Interest (avg)
-20.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.88
Sales to Capital Employed (avg)
0.01
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-3.86
EV to EBIT
-3.72
EV to EBITDA
-3.82
EV to Capital Employed
-38.52
EV to Sales
63.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.80
-10.10
92.08%
Interest
0.30
0.40
-25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.10
-7.30
84.93%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is 84.93% vs -329.41% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-15.40
-21.20
27.36%
Interest
1.30
0.90
44.44%
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-13.20
-10.10
-30.69%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -30.69% vs 60.55% in Dec 2023
About Pure Biologics SA 
Pure Biologics SA
Pharmaceuticals & Biotechnology
Pure Biologics SA is a manufacturer of biological products. The Company was founded in August 2010 and is located in Wroclaw, Poland.
Company Coordinates 
Company Details
Ul. Dunska 11 , WROCLAW None : 54-427
Registrar Details






